← back to search

Stefan Goldberg

Centers for Disease Control and Prevention · US
Area of research
Infectious Diseases · Surgery
Research interest
Research interests include Tuberculosis Research and Epidemiology, Infectious Diseases and Tuberculosis, Mycobacterium research and diagnosis, and Diagnosis and treatment of tuberculosis.
h-index
31
citations
5,111
works
60
NIH funding
—
primary concept
Medicine
email
✉ Find email ↗

Recent publications

Four-Month Rifapentine Regimens with or without Moxifloxacin for Tuberculosis
New England Journal of Medicine 2021cited by 542position: middledoi
High-dose rifapentine with or without moxifloxacin for shortening treatment of pulmonary tuberculosis: Study protocol for TBTC study 31/ACTG A5349 phase 3 clinical trial
Contemporary Clinical Trials 2020cited by 56position: middledoi
Comparison of different treatments for isoniazid-resistant tuberculosis: an individual patient data meta-analysis
The Lancet Respiratory Medicine 2018cited by 109position: middledoi
Factors Associated With Noncompletion of Latent Tuberculosis Infection Treatment: Experience From the PREVENT TB Trial in the United States and Canada
Clinical Infectious Diseases 2016cited by 46position: lastdoi
Daily Rifapentine for Treatment of Pulmonary Tuberculosis. A Randomized, Dose-Ranging Trial
American Journal of Respiratory and Critical Care Medicine 2014cited by 112position: middledoi
The Association between Symptoms and Microbiologically Defined Response to Tuberculosis Treatment
Annals of the American Thoracic Society 2013cited by 26position: middledoi
Substitution of Rifapentine for Rifampin During Intensive Phase Treatment of Pulmonary Tuberculosis: Study 29 of the Tuberculosis Trials Consortium
The Journal of Infectious Diseases 2012cited by 110position: middledoi

Grants

No grants ingested yet.

Frequent collaborators

John L. Johnson · CTS Corporation (United States)3 papers (2012–2014)— · 3 papers (2012–2016)Andrew Vernon · Centers for Disease Control and Prevention3 papers (2012–2014)Charles M. Heilig · Centers for Disease Control and Prevention3 papers (2012–2014)Grace Muzanyi · University Hospitals of Cleveland3 papers (2012–2014)Jason E. Stout · Duke University2 papers (2012–2014)Neil W. Schluger · Westchester Medical Center2 papers (2012–2014)Jussi Saukkonen · Boston University2 papers (2013–2016)— · 2 papers (2012–2014)Eric Nuermberger · Johns Hopkins University2 papers (2012–2014)Susan E. Dorman · Medical University of South Carolina2 papers (2012–2014)— · 2 papers (2013–2016)Payam Nahid · Global Brain Health Institute2 papers (2012–2014)Marc Weiner · Hôpital Beau-Séjour2 papers (2012–2014)Masahiro Narita · Public Health – Seattle & King County1 papers (2012–2012)— · 1 papers (2016–2016)Nigel Scott · Centers for Disease Control and Prevention1 papers (2016–2016)— · 1 papers (2012–2012)Richard E. Chaisson · Alexandra Hospital1 papers (2013–2013)— · 1 papers (2014–2014)